Utility of Peak Anti-Xa Monitoring in High-Risk Bleeding Patients on Low Molecular Weight Heparin – Can it Guide us to Safe Dosing of Low-Molecular Weight Heparin (Lmwh)
1. Summary Three elderly patients were given LMWH for treatment of Venous Thromboembolism and stroke prevention on background of Atrial Fibrillation. All of them had high bleeding risks from various reasons, such as recent brain surgery with post-operative intracranial hematoma, large liver mass (>10cm) possibly newly diagnosed Hepatocellular Carcinoma, and lastly intramuscular hematoma from supra-therapeutic …